期刊文献+

玻璃体腔注射地塞米松治疗氩激光诱导兔视网膜水肿的实验研究 被引量:2

Experimental study on intravitreous injection with dexamethasone for retinal edema of argon laser-induced in rabbits
原文传递
导出
摘要 目的通过观察玻璃体腔注射地塞米松(DEX)后对兔视网膜水肿的光学相干断层扫描(OCT)的影响及视网膜组织病理学改变,探讨DEX对兔视网膜水肿的治疗作用。方法健康有色家兔40只均对右眼采用氩激光直接光凝法封闭视网膜静脉建立视网膜水肿模型,随机分为实验组及对照组。实验组20只兔在造模后1d右眼玻璃体腔注射DEX1mg/0.2ml,对照组20只兔在造模后1d右眼玻璃体腔注射平衡盐溶液1mg/0.2ml,40只兔左眼不做任何处理作为正常对照组。实验组和对照组再根据处死时间不同分为注药后12h、1d、3d、5d四个亚组(每组5只),并于各时间点行OCT检查,然后处死实验兔,光镜下观察视网膜组织病理学变化。结果40只兔均成功建立兔视网膜水肿模型,OCT检查示注药后1d、3d、5d实验组兔视网膜厚度明显小于对照组,差异有统计学意义(P<0.05)。光镜下观察实验组组织形态改变优于对照组。结论DEX短期内能够有效减轻视网膜水肿,保护视网膜功能。 Objective To observe optical coherence tomography and morphology changes after intravitreous injection with dexamethasone for macular edema in rabbits,we explored whether dexamethasone can lessen the retinal edema.Methods The model of retinal edema was established with argon laser photocoagulation to retinal vein in fourty right eyes of healthy pigment rabbits and then divided into control group and DEX groups.The right eyes of DEX group was injected with dexamethasone 1 mg/0.2 ml and the right eyes of control group was injected with balancing salt solution 1 mg/0.2 ml.The fourty left eyes didn't do anything as the normal control group.Control group and DEX groups respectively according to different killing time divided into 12 h,1 d,3 d and 5 d four groups(5 rabbits in each group).In every time,each animal was examined by OCT and observed retinal tissue pathology by light microscopy after killing.Results The model of retinal edema was established in all the eyes.The retinal thickness in DEX group was obviously less than control group in 1 d,3 d and 5 d by OCT(P0.05).The pathologic changes in DEX group was better than that in control group.Conclusions DEX could effectively reduce retinal edema and protect the retina function in short time.
出处 《中华临床医师杂志(电子版)》 CAS 2010年第2期29-32,共4页 Chinese Journal of Clinicians(Electronic Edition)
关键词 黄斑水肿 视网膜静脉闭塞 地塞米松 体层摄影术 光学相干 Macular edema Retinal vein occlusion Dexamethasone Tomography optical coherence
  • 相关文献

参考文献3

二级参考文献65

  • 1王建洲,惠延年,王雨生,张鹏,马吉献,张自峰,郭长梅,徐渊.一种简易的兔视网膜脱离模型[J].眼科新进展,2004,24(5):352-354. 被引量:8
  • 2马成,黄洁成,茅彦.玻璃体切割术联合曲安奈德治疗难治性黄斑水肿的疗效分析[J].中国实用眼科杂志,2006,24(6):562-564. 被引量:5
  • 3魏欣,邓应平.循证医学与黄斑囊样水肿非类固醇抗炎药应用的选择[J].中国临床康复,2006,10(36):158-159. 被引量:2
  • 4黄渝侃,王智,张明昌.卵磷脂络合碘对CSC激光治疗后黄斑水肿吸收的影响[J].眼科研究,2006,24(5):546-548. 被引量:4
  • 5[18]Kaderli B,Avci R.Gelisken O,etc.Intravitreal triamcinolone as an adjunct in the treatment of concomitant proliferative diabetic retinopathy and diffuse diabetic macular oedema.combined IVTA and laser treatment for PDR with CSMO.Int Ophthalmol.2005,26:207-14.Epub 2007,14.
  • 6[5]Kobayashi H,Kobayashi K,Okinami S.Randomized clinical trial of topical betaxoloI for persistent macular edema after vitrectomv and epiretinal membrane removal.Am J Ophthalmol,2003.36:244251.
  • 7[9]Young jae cou,MD;In kyung oh,MD etc.intravitreal Versus posterior subtenon injection of triamcimolone acetonide for diabetic macular edema.Korean J Ophthalmol 2006,20:205-9.
  • 8[10]Nguyen QD,Tatlipilar S etc,Vascular endothelial growth factor is a critical stimulus for dialmtic macular edema.Am J Ophthalmol.2006,142:961-9.Epub 2006 Aug 2.
  • 9[11]Jorge R,Costa RA,Calucei D etc,intravitreal bevacizumab(Avastin)for persistent new vessels in diahetic Dretinopathy(IBEPE study),Retina,2006,26:1006-13.
  • 10[12]Haritoglou C,Kook D.Neubauer A etc,Intravitreal bevacizumab(Avastin)therapy for persistent diffuse diabetic macular edema,Retina 2006,26(9):1006-13.

共引文献49

同被引文献12

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部